https://doi.org/10.4081/hmr.v3i1.552

Allogeneic transplantation for peripheral and cutaneous T-cell lymphomas

Vol. 3 No. 1: 2006...2009: Now we know T-cell lymphomas better, Bologna, Italy, 16-18 March 2009
Published: June 11, 2009
Abstract Views: 219
PDF: 168
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

P Corradini
support@pagepress.org
A Dodero
G Lambertenghi-Deliliers
F Onida
Few studies have evaluated the role of allogeneic stem cell transplantation (SCT) in peripheral Tcell lymphomas (PTCL). Recent reports have evaluated allogeneic SCT exclusively in relapsed setting and showed an evidence for a graft-versus-lymphoma effect (GVL). In this report we extended our previous observations to 38 patients. All patients received several courses of debulkying chemotherapy followed by allogeneic SCT with a reduced intensity conditioning (RIC) regimen. Patients’ median age was 45 years (range, 15-64). Histologic PTCL subtypes included: unspecified (n=15), ALCL (n=9), AILD (n=5), intestinal (n=3), other subtypes (n=6). Twenty-eight pts (74%) received transplant from HLA-identical sibling donors, 5 from haploidentical donors (13%) and 5 from unrelated donors (13%). The median time from diagnosis to allogeneic SCT was 16.4 months. Twenty-one patients (55%) had failed a previous autologous SCT. Twenty-eight (73%) had chemosensitive disease (n=13 in CR, n=15 in PR). Ten patients received low dose alemtuzumab in the conditioning regimen for GVHD prophylaxis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Corradini, P., Dodero, A., Lambertenghi-Deliliers, G., & Onida, F. (2009). Allogeneic transplantation for peripheral and cutaneous T-cell lymphomas. Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.552
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).